Corcept Therapeutics Incorporated Common Stock (CORT)

About CORT

Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. The company offers Korlym, an oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus o…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

730

Website

www.corcept.com

Fundamentals

1-day range

$108.08$110.79

Market cap

$11.67B

P/E (trailing)

246.16

P/E (forward)

24.52

EPS (trailing)

$0.45

Dividend yield

—

Beta

0.46

Avg. volume

1.17M

Forecasts

4 analyst ratings

Corcept Therapeutics Incorporated Common Stock Competitors

Chosen by industry and closest market cap.

• CORT

  Corcept Therapeutics Incorporated Common Stock

  $113.88

  ▼ 2.61%
  Market cap $11.67BP/E 246.16
  $28.66$122.21
• MDGL

  Madrigal Pharmaceuticals Inc. Common Stock

  $534.12

  ▼ 1.76%
  Market cap $11.79BP/E —
  $393.61$615
• ELAN

  Elanco Animal Health Incorporated Common Stock

  $24.12

  ▼ 1.51%
  Market cap $12.09BP/E —
  $17.11$27.98
• ABVX

  Abivax SA American Depositary Shares

  $113.41

  ▼ 0.78%
  Market cap $11.19BP/E —
  $60.45$139
• AXSM

  Axsome Therapeutics Inc. Common Stock

  $199.01

  ▼ 3.52%
  Market cap $10.81BP/E —
  $112.9$260.19
• SMMT

  Summit Therapeutics Inc. Common Stock

  $13.71

  ▼ 4.33%
  Market cap $10.80BP/E —
  $12.07$29.23
• PRAX

  Praxis Precision Medicines Inc. Common Stock

  $344.95

  ▼ 6.23%
  Market cap $10.32BP/E —
  $37.19$392.7

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Like The Knick's, Corcept Rebounded And Is Crushing It
  SeekingAlpha · 8/21/2026
• Corcept Therapeutics: LIFYORLI Is Likely A Blockbuster, But The Valuation Already Knows It
  SeekingAlpha · 7/31/2026

• Gary Charles Robb · August 12, 2026 · Gift

  3.0K
• Gary Charles Robb · August 12, 2026 · Gift

  11.5K
• Sean Maduck · August 10, 2026 · Option Exercise

  1.0K @ $8.27
• Sean Maduck · August 10, 2026 · Sale

  1.0K @ $114.52
• William Guyer · August 10, 2026 · Option Exercise

  16.3K @ $21.65
• William Guyer · August 10, 2026 · Sale

  4.8K @ $114.04
• William Guyer · August 10, 2026 · Sale

  11.5K @ $113.18
• William Guyer · August 4, 2026 · Option Exercise

  3.7K @ $21.65
• William Guyer · August 4, 2026 · Sale

  3.7K @ $113.12
• Sean Maduck · August 3, 2026 · Option Exercise

  20.3K @ $8.27
• Sean Maduck · August 3, 2026 · Sale

  20.3K @ $114.7
• Joseph Douglas Lyon · August 3, 2026 · Sale

  1.5K @ $114.16
• Atabak Mokari · July 30, 2026 · Option Exercise

  80.0K @ $23.06
• Atabak Mokari · July 30, 2026 · Sale

  1.0K @ $120.67
• Atabak Mokari · July 30, 2026 · Sale

  8.1K @ $119.95

Institutional Ownership

March 31, 2026

Total shares held

76.50M

Total value held

$2.73B

Institutional holders

341